293 related articles for article (PubMed ID: 32889240)
1. Increased Galectin-9 expression, a prognostic biomarker of aGVHD, regulates the immune response through the Galectin-9 induced MDSC pathway after allogeneic hematopoietic stem cell transplantation.
Yin J; Li L; Wang C; Zhang Y
Int Immunopharmacol; 2020 Nov; 88():106929. PubMed ID: 32889240
[TBL] [Abstract][Full Text] [Related]
2. Circulating CD14(+) HLA-DR(-/low) myeloid-derived suppressor cells in leukemia patients with allogeneic hematopoietic stem cell transplantation: novel clinical potential strategies for the prevention and cellular therapy of graft-versus-host disease.
Yin J; Wang C; Huang M; Mao X; Zhou J; Zhang Y
Cancer Med; 2016 Jul; 5(7):1654-69. PubMed ID: 27109254
[TBL] [Abstract][Full Text] [Related]
3. Umbilical cord blood-derived mesenchymal stromal cells promote myeloid-derived suppressor cell proliferation by secreting HLA-G to reduce acute graft-versus-host disease after hematopoietic stem cell transplantation.
Yang S; Wei Y; Sun R; Lu W; Lv H; Xiao X; Cao Y; Jin X; Zhao M
Cytotherapy; 2020 Dec; 22(12):718-733. PubMed ID: 32811747
[TBL] [Abstract][Full Text] [Related]
4. Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia.
Fan Q; Liu H; Liang X; Yang T; Fan Z; Huang F; Ling Y; Liao X; Xuan L; Xu N; Xu X; Ye J; Liu Q
J Hematol Oncol; 2017 Jul; 10(1):135. PubMed ID: 28676100
[TBL] [Abstract][Full Text] [Related]
5. [Prediction of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation by the level of galectin-9 in peripheral blood].
Yin J; Cao Y; Zhou JF; Zhang YC
Zhonghua Xue Ye Xue Za Zhi; 2020 Jan; 41(1):23-27. PubMed ID: 32023750
[No Abstract] [Full Text] [Related]
6. Monocytic and promyelocytic myeloid-derived suppressor cells may contribute to G-CSF-induced immune tolerance in haplo-identical allogeneic hematopoietic stem cell transplantation.
Lv M; Zhao XS; Hu Y; Chang YJ; Zhao XY; Kong Y; Zhang XH; Xu LP; Liu KY; Huang XJ
Am J Hematol; 2015 Jan; 90(1):E9-E16. PubMed ID: 25303038
[TBL] [Abstract][Full Text] [Related]
7. Circulating angiogenic factors associated with response and survival in patients with acute graft-versus-host disease: results from Blood and Marrow Transplant Clinical Trials Network 0302 and 0802.
Holtan SG; Verneris MR; Schultz KR; Newell LF; Meyers G; He F; DeFor TE; Vercellotti GM; Slungaard A; MacMillan ML; Cooley SA; Blazar BR; Panoskaltsis-Mortari A; Weisdorf DJ
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1029-36. PubMed ID: 25759146
[TBL] [Abstract][Full Text] [Related]
8. Myeloid-Derived Suppressor Cells in the Context of Allogeneic Hematopoietic Stem Cell Transplantation.
D'Aveni M; Notarantonio AB; Bertrand A; Boulangé L; Pochon C; Rubio MT
Front Immunol; 2020; 11():989. PubMed ID: 32528476
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulation effects of mesenchymal stromal cells on acute graft-versus-host disease after hematopoietic stem cell transplantation.
Zhao K; Lou R; Huang F; Peng Y; Jiang Z; Huang K; Wu X; Zhang Y; Fan Z; Zhou H; Liu C; Xiao Y; Sun J; Li Y; Xiang P; Liu Q
Biol Blood Marrow Transplant; 2015 Jan; 21(1):97-104. PubMed ID: 25300866
[TBL] [Abstract][Full Text] [Related]
10. Galectin-3 expression in donor T cells reduces GvHD severity and lethality after allogeneic hematopoietic cell transplantation.
Mohammadpour H; Tsuji T; MacDonald CR; Sarow JL; Rosenheck H; Daneshmandi S; Choi JE; Qiu J; Matsuzaki J; Witkiewicz AK; Attwood K; Blazar BR; Odunsi K; Repasky EA; McCarthy PL
Cell Rep; 2023 Mar; 42(3):112250. PubMed ID: 36924493
[TBL] [Abstract][Full Text] [Related]
11. Graft-Versus-Host Disease Prevention by
Scheurer J; Kitt K; Huber HJ; Fundel-Clemens K; Pflanz S; Debatin KM; Strauss G
Front Immunol; 2021; 12():754316. PubMed ID: 34721430
[TBL] [Abstract][Full Text] [Related]
12. Contrasting acute graft-versus-host disease effects of Tim-3/galectin-9 pathway blockade dependent upon the presence of donor regulatory T cells.
Veenstra RG; Taylor PA; Zhou Q; Panoskaltsis-Mortari A; Hirashima M; Flynn R; Liu D; Anderson AC; Strom TB; Kuchroo VK; Blazar BR
Blood; 2012 Jul; 120(3):682-90. PubMed ID: 22677125
[TBL] [Abstract][Full Text] [Related]
13. The level of Tim-3+CD8+ T cells can serve as a potential marker for evaluating the severity of acute graft-versus-host disease after haplo-PBSCT.
Pang N; Yu M; Xu J; Yuan H; Chen G; Wang D; Han C; Wang W; Ding J; Jiang M
Braz J Med Biol Res; 2023; 56():e12997. PubMed ID: 38126537
[TBL] [Abstract][Full Text] [Related]
14. Graft invariant natural killer T-cell dose predicts risk of acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation.
Chaidos A; Patterson S; Szydlo R; Chaudhry MS; Dazzi F; Kanfer E; McDonald D; Marin D; Milojkovic D; Pavlu J; Davis J; Rahemtulla A; Rezvani K; Goldman J; Roberts I; Apperley J; Karadimitris A
Blood; 2012 May; 119(21):5030-6. PubMed ID: 22371885
[TBL] [Abstract][Full Text] [Related]
15. γδ T Cells May Aggravate Acute Graft-Versus-Host Disease Through CXCR4 Signaling After Allogeneic Hematopoietic Transplantation.
Wu N; Liu R; Liang S; Gao H; Xu LP; Zhang XH; Liu J; Huang XJ
Front Immunol; 2021; 12():687961. PubMed ID: 34335589
[TBL] [Abstract][Full Text] [Related]
16. [The role of third-party tolerogenic dendritic cells in the prevention of acute graft-versus-host-disease following allogeneic bone marrow transplantation in mice].
Li GP; Yang J; Hao J; Yang YM; Ren YN; Xie RF; Fan HH; Qian KC
Zhonghua Xue Ye Xue Za Zhi; 2012 Jun; 33(6):461-6. PubMed ID: 22967381
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxicity of Donor Natural Killer Cells to Allo-Reactive T Cells Are Related With Acute Graft-vs.-Host-Disease Following Allogeneic Stem Cell Transplantation.
Sheng L; Mu Q; Wu X; Yang S; Zhu H; Wang J; Lai Y; Wu H; Sun Y; Hu Y; Fu H; Wang Y; Xu K; Sun Y; Zhang Y; Zhang P; Zhou M; Lai B; Xu Z; Gao M; Zhang Y; Ouyang G
Front Immunol; 2020; 11():1534. PubMed ID: 32849519
[No Abstract] [Full Text] [Related]
18. Associations between acute GVHD-related biomarkers and endothelial cell activation after allogeneic hematopoietic stem cell transplantation.
Nomura S; Ishii K; Fujita S; Nakaya A; Satake A; Ito T
Transpl Immunol; 2017 Aug; 43-44():27-32. PubMed ID: 28687251
[TBL] [Abstract][Full Text] [Related]
19. Influence of post-transplant mucosal-associated invariant T cell recovery on the development of acute graft-versus-host disease in allogeneic bone marrow transplantation.
Kawaguchi K; Umeda K; Hiejima E; Iwai A; Mikami M; Nodomi S; Saida S; Kato I; Hiramatsu H; Yasumi T; Nishikomori R; Kondo T; Takaori-Kondo A; Heike T; Adachi S
Int J Hematol; 2018 Jul; 108(1):66-75. PubMed ID: 29582333
[TBL] [Abstract][Full Text] [Related]
20. Functional Myeloid-Derived Suppressor Cell Subsets Recover Rapidly after Allogeneic Hematopoietic Stem/Progenitor Cell Transplantation.
Guan Q; Blankstein AR; Anjos K; Synova O; Tulloch M; Giftakis A; Yang B; Lambert P; Peng Z; Cuvelier GD; Wall DA
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1205-14. PubMed ID: 25963921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
